WEREWOLF THERAPEUTICS INC's ticker is HOWL and the CUSIP is 95075A107. A total of 46 filers reported holding WEREWOLF THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,119,006 | -29.8% | 522,900 | 0.0% | 0.01% | -22.2% |
Q2 2023 | $1,594,845 | +17.3% | 522,900 | 0.0% | 0.01% | 0.0% |
Q1 2023 | $1,359,540 | +26.8% | 522,900 | 0.0% | 0.01% | +80.0% |
Q4 2022 | $1,071,945 | -54.5% | 522,900 | 0.0% | 0.01% | -64.3% |
Q3 2022 | $2,358,000 | +7.7% | 522,900 | -2.3% | 0.01% | -58.8% |
Q2 2022 | $2,189,000 | – | 535,160 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DC Funds, LP | 589,102 | $10,274,000 | 48.81% |
MPM ASSET MANAGEMENT LLC | 4,284,172 | $74,716,000 | 13.89% |
MPM BioImpact LLC | 2,388,011 | $41,647,000 | 6.84% |
Soleus Capital Management, L.P. | 563,396 | $9,826,000 | 1.51% |
RA Capital Management | 4,291,881 | $74,850,000 | 1.20% |
SPHERA FUNDS MANAGEMENT LTD. | 706,294 | $12,049,000 | 0.82% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,552,787 | $44,521,000 | 0.79% |
Nicholas Investment Partners, LP | 294,654 | $5,139,000 | 0.32% |
Avidity Partners Management LP | 650,265 | $11,341,000 | 0.31% |
PFM Health Sciences, LP | 400,000 | $6,976,000 | 0.22% |